Literature DB >> 17050040

Mortalin is regulated by APOE in hippocampus of AD patients and by human APOE in TR mice.

Cristina Osorio1, Patrick M Sullivan, Dong Ning He, Brian E Mace, John F Ervin, Warren J Strittmatter, Oscar Alzate.   

Abstract

Mortalin is a chaperone protein associated with cell survival, stress response, intracellular trafficking, control of cell proliferation, mitochondrial biogenesis, and cell fate determination. Human APOE targeted replacement (TR) mice have been used to elucidate the role of APOE4 in Alzheimer's disease (AD), since these animals express the APOE4 gene without the classical pathological signatures of AD. Using proteomics we found that mortalin isoforms are differentially expressed in the hippocampus of APOE4 TR mice compared with the APOE3 (control) TR mice. We also observed that these mortalin isoforms are differentially phosphorylated. Then we studied mortalin expression in patients with AD (genotypes APOE 3/3 and APOE 4/4) compared with patients without AD (genotype APOE 3/3). We observed that mortalin isoforms are also differentially expressed in the hippocampi of patients with AD, and that the expression of these mortalin isoforms is regulated by the APOE genotype. We propose that the differential regulation of mortalin in AD and by the APOE genotype is a cellular defense mechanism responding to increases in oxidative stress.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17050040     DOI: 10.1016/j.neurobiolaging.2006.08.011

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  23 in total

Review 1.  Apolipoprotein E and oxidative stress in brain with relevance to Alzheimer's disease.

Authors:  D Allan Butterfield; Mark P Mattson
Journal:  Neurobiol Dis       Date:  2020-02-06       Impact factor: 5.996

2.  Evidence for Mitochondrial UPR Gene Activation in Familial and Sporadic Alzheimer's Disease.

Authors:  John S Beck; Elliott J Mufson; Scott E Counts
Journal:  Curr Alzheimer Res       Date:  2016       Impact factor: 3.498

3.  Down-regulation of mortalin exacerbates Aβ-mediated mitochondrial fragmentation and dysfunction.

Authors:  So Jung Park; Ji Hyun Shin; Jae In Jeong; Ji Hoon Song; Yoon Kyung Jo; Eun Sung Kim; Eunjoo H Lee; Jung Jin Hwang; Eun Kyung Lee; Sun Ju Chung; Jae-Young Koh; Dong-Gyu Jo; Dong-Hyung Cho
Journal:  J Biol Chem       Date:  2013-12-09       Impact factor: 5.157

4.  Polymerase I and transcript release factor (PTRF) regulates adipocyte differentiation and determines adipose tissue expandability.

Authors:  Sergio Perez-Diaz; Lance A Johnson; Robert M DeKroon; Jose M Moreno-Navarrete; Oscar Alzate; Jose M Fernandez-Real; Nobuyo Maeda; Jose M Arbones-Mainar
Journal:  FASEB J       Date:  2014-05-08       Impact factor: 5.191

Review 5.  Glycoproteomics in neurodegenerative diseases.

Authors:  Hyejin Hwang; Jianpeng Zhang; Kathryn A Chung; James B Leverenz; Cyrus P Zabetian; Elaine R Peskind; Joseph Jankovic; Zhen Su; Aneeka M Hancock; Catherine Pan; Thomas J Montine; Sheng Pan; John Nutt; Roger Albin; Marla Gearing; Richard P Beyer; Min Shi; Jing Zhang
Journal:  Mass Spectrom Rev       Date:  2010 Jan-Feb       Impact factor: 10.946

Review 6.  Proteomics in animal models of Alzheimer's and Parkinson's diseases.

Authors:  Renã A Sowell; Joshua B Owen; D Allan Butterfield
Journal:  Ageing Res Rev       Date:  2008-07-18       Impact factor: 10.895

7.  Profiling of experience-regulated proteins in the songbird auditory forebrain using quantitative proteomics.

Authors:  Raphael Pinaud; Cristina Osorio; Oscar Alzate; Erich D Jarvis
Journal:  Eur J Neurosci       Date:  2008-03       Impact factor: 3.386

8.  Proteomic and immunologic analyses of brain tumor exosomes.

Authors:  Michael W Graner; Oscar Alzate; Angelika M Dechkovskaia; Jack D Keene; John H Sampson; Duane A Mitchell; Darell D Bigner
Journal:  FASEB J       Date:  2008-12-24       Impact factor: 5.191

9.  Proteomic identification of dopamine-conjugated proteins from isolated rat brain mitochondria and SH-SY5Y cells.

Authors:  Victor S Van Laar; Amanda J Mishizen; Michael Cascio; Teresa G Hastings
Journal:  Neurobiol Dis       Date:  2009-03-28       Impact factor: 5.996

Review 10.  Clinical implications from proteomic studies in neurodegenerative diseases: lessons from mitochondrial proteins.

Authors:  D Allan Butterfield; Erika M Palmieri; Alessandra Castegna
Journal:  Expert Rev Proteomics       Date:  2016       Impact factor: 3.940

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.